Skip to main content
Genetic Technologies Limited (GENE)
NASDAQ: GENE · IEX Real-Time Price · USD
0.823
+0.029 (3.69%)
At close: Jul 26, 2024, 1:19 PM
0.850
+0.027 (3.29%)
After-hours: Jul 26, 2024, 6:23 PM EDT

Genetic Technologies Revenue

Genetic Technologies had revenue of 4.87M AUD in the half year ending December 31, 2023, with 41.04% growth. This brings the company's revenue in the last twelve months to 10.24M, down -4.64% year-over-year. In the fiscal year ending June 30, 2023, Genetic Technologies had annual revenue of 10.35M with 12.25% growth.

Revenue (ttm)
10.24M AUD
Revenue Growth
-4.64%
P/S Ratio
0.74
Revenue / Employee
170,718 AUD
Employees
60
Market Cap
4.32M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 202310.35M1.13M12.25%
Jun 30, 20229.22M7.88M590.65%
Jun 30, 20211.33M496.87K59.30%
Jun 30, 2020837.87K812.42K3,192.98%
Jun 30, 201925.44K-163.81K-86.56%
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Jun 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evoke Pharma 6.11M
Intelligent Bio Solutions 3.21M
Predictive Oncology 1.96M
Sonnet BioTherapeutics Holdings 92.73K
Creative Medical Technology Holdings 9.00K
Revenue Rankings

GENE News

More News